QUADRANT CAPITAL GROUP LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,381
+371.1%
3,590
+638.7%
0.00%
Q2 2023$2,416
-11.7%
486
-12.3%
0.00%
Q1 2023$2,737
+1111.1%
554
+1438.9%
0.00%
Q4 2022$226
-97.5%
36
-95.6%
0.00%
-100.0%
Q3 2022$9,0000.0%8260.0%0.00%0.0%
Q2 2022$9,000
-30.8%
826
-41.5%
0.00%
-50.0%
Q1 2022$13,000
+160.0%
1,413
+294.7%
0.00%
+100.0%
Q4 2021$5,000
+150.0%
358
+316.3%
0.00%
Q3 2021$2,00086
+975.0%
0.00%
Q2 2021$080.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders